Crescendo Biologics rakes in $70 mln Series B
UK-based Crescendo Biologics Ltd, a biopharmaceutical company, has closed $70 million in Series B financing. Andera Partners led the round with participation from other investors that included Quan Capital.
30 April 2018•1 min read
